Expression of four CEA family antigens (CEA, NCA, BGP and CGM2) in normal and cancerous gastric epithelial cells: up-regulation of BGP and CGM2 in carcinomas.
about
CEACAM1: contact-dependent control of immunityCharacterization of gastric adenocarcinoma cell lines established from CEA424/SV40 T antigen-transgenic mice with or without a human CEA transgene.Dynamic expression of CEACAM7 in precursor lesions of gastric carcinoma and its prognostic value in combination with CEA.CEACAM1 long cytoplasmic domain isoform is associated with invasion and recurrence of hepatocellular carcinoma.CEACAM6 as detected by the AP11 antibody is a marker notable for mucin-producing adenocarcinomas.Hollow spheroids beyond the invasive margin indicate the malignant potential of colorectal cancer.Association of VCAM-1 overexpression with oncogenesis, tumor angiogenesis and metastasis of gastric carcinoma.Gene expression profiles in human gastric cancer: expression of maspin correlates with lymph node metastasisMajor Protein of Carcinoembryonic Antigen Gene Family - CD66c, A Novel Marker in Colon CarcinomaNovel antibodies as anticancer agents.Characterizing CEACAM5 interaction with CD8α and CD1d in intestinal homeostasis.Up-regulation of carcinoembryonic antigen-related cell adhesion molecule 1 in gastrointestinal cancer and its clinical relevance.CEACAM1 enhances invasion and migration of melanocytic and melanoma cells.Vitamin D inhibits CEACAM1 to promote insulin/IGF-I receptor signaling without compromising anti-proliferative action.CEACAM1 impedes thyroid cancer growth but promotes invasiveness: a putative mechanism for early metastases.Expression of CD66a in multiple myeloma.cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function.CEACAM1 is overexpressed in oral tumors and related to tumorigenesis.
P2860
Q28242244-9E433BB1-08C1-4EA6-8E27-7A812F01B196Q33236456-D6C6AD04-AF64-4382-9B9B-C9299D8B93AEQ34111227-153FAE5B-8451-4AB9-B027-0C9AC1CE1F8AQ34435766-CA00650C-2C53-4DF1-9F8F-9020CF033D6AQ35075187-FBB606BA-34E2-4A63-AB5C-CDF63A8CBDADQ35322339-61434618-6F17-4F8E-80AA-9F437AB15D6AQ36190607-8290C8F9-C035-4E34-9230-61A6547D8252Q36616424-F91A2764-2DC0-4F3A-87F6-8CFE66F055A4Q36708808-7B907826-EA0E-4F59-927E-97988C12D4F3Q36832141-3B169C41-1EC6-4768-9FB3-EABEBFE688A1Q38686599-D7F8B8EF-EE6D-4933-A8DB-44E24D370A3FQ38706556-A7B86833-0547-494E-B50E-AEFC5C8C2B38Q38783190-A417B738-2A9F-4ECE-924A-384180B7C397Q39666830-46DFFEA5-A287-4745-9055-72DB7E610ED5Q40216819-FE86F7A9-A979-49F2-B638-AB66F60BD5D3Q40738709-8894B14F-EF06-4275-A132-15A46E90D38CQ42809766-7F4C341E-F104-4DF2-A63F-4A281840E5A2Q51612628-535451F2-1CD6-4AEB-B5D0-421B83FFB89E
P2860
Expression of four CEA family antigens (CEA, NCA, BGP and CGM2) in normal and cancerous gastric epithelial cells: up-regulation of BGP and CGM2 in carcinomas.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Expression of four CEA family ...... of BGP and CGM2 in carcinomas.
@ast
Expression of four CEA family ...... of BGP and CGM2 in carcinomas.
@en
Expression of four CEA family ...... of BGP and CGM2 in carcinomas.
@nl
type
label
Expression of four CEA family ...... of BGP and CGM2 in carcinomas.
@ast
Expression of four CEA family ...... of BGP and CGM2 in carcinomas.
@en
Expression of four CEA family ...... of BGP and CGM2 in carcinomas.
@nl
prefLabel
Expression of four CEA family ...... of BGP and CGM2 in carcinomas.
@ast
Expression of four CEA family ...... of BGP and CGM2 in carcinomas.
@en
Expression of four CEA family ...... of BGP and CGM2 in carcinomas.
@nl
P2093
P1476
Expression of four CEA family ...... of BGP and CGM2 in carcinomas.
@en
P2093
T Kinugasa
T Shirakusa
Y Matsuoka
Y Yamashita
P304
P356
10.1002/(SICI)1097-0215(19980330)76:1<148::AID-IJC23>3.0.CO;2-7
P577
1998-03-01T00:00:00Z